Hybrid atrial fibrillation ablation in patients with persistent atrial fibrillation or failed catheter ablation

BACKGROUND: Combined ‘hybrid’ thoracoscopic and percutaneous atrial fibrillation (AF) ablation is a strategy used to treat AF in patients with therapy-resistant symptomatic AF. We aimed to study efficacy and safety of single-stage hybrid AF ablation in patients with symptomatic persistent AF, or par...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Jazairi, M. I. H., Rienstra, M., Klinkenberg, T. J., Mariani, M. A., Van Gelder, I. C., Blaauw, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393682/
https://www.ncbi.nlm.nih.gov/pubmed/30715671
http://dx.doi.org/10.1007/s12471-019-1228-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393682/
https://www.ncbi.nlm.nih.gov/pubmed/30715671
http://dx.doi.org/10.1007/s12471-019-1228-3

Ejemplares similares